Philip Morris
Is the Concept of A Linear Relationship Between Dose and Effect Still A Valid Model for Assessing Risks Related to Low Doses of Carcinogens - the D.D.T. Example.
Fields
- Author
- Hazeltine, W.
- Named Person
- Agthe
- Axelrod, L.
- Carson, R.
- Datta, P.R.
- Delaney
- Durham
- Ehrlich
- Epstein, S.
- Falk, H.
- Fitzhugh, O.G.
- Fouts, J.R.
- Gillett, J.W.
- Hart
- Hayes
- Hazeltine, W.
- Innes
- Kimbrough, R.
- Laws, E.R.
- Lehman
- Lyon
- Milan
- Mrak
- Nelson
- Okey, A.B.
- Ottoboni, M.A.
- Rappolt, R.
- Salinskas, K.C.
- Schneiderman, M.
- Terracini
- Thompson, Rph
- Tomatis, L.
- Turusov
- Walker, E.M.
- Weil, C.S.
- Zzesa
- Axelrod, L.
- Type
- SCRT, REPORT, SCIENTIFIC
- CHAR, CHART, GRAPH, TABLE, MAPS
- Site
- E12
- Document File
- 2502145956/2502146352/Thresholds 4
- Characteristic
- ILLE, ILLEGIBLE
- MARG, MARGINALIA
- Master ID
- 2502146051/6295
Related Documents:- 2502146051 Paris Conference on Low Doses of Carcinogens
- 2502146065-6068 Is the Concept of Linear Relationship Between Dose and Effect Still A Valid Model for Assessing Risk Related to Low Doses of Carcinogens? 930510 - Paris
- 2502146069 the Causes and Prevention of Cancer Prof. Bruce N. Ames
- 2502146070-6071 the Causes and Prevention of Cancer
- 2502146072 How Biologically Based Models May Help Extrapolating Cancer Risk to Low Doses Prof. Georg Luebeck
- 2502146073-6079 How Biologically Based Models May Help Extrapolating Cancer Risk to Low Doses
- 2502146080 A Critical Study of Methods of Assessment of Effects of Low Doses Prof. Etienne Fournier
- 2502146081-6098 A Critical Study of Methods of Assessment of the Effects of Low Doses
- 2502146099 Do Rodent Studies Predict Human Cancers? Prof. Aaron Wildavsky
- 2502146100-6143 Do Rodent Studies Predict Human Cancers?
- 2502146144 the Delaney Clause-Linchpin of the Environmental Policy Edifice Prof. S. Fred Singer
- 2502146145-6146 Delaney Clause - Linchpin of the Environmental Policy Edifice
- 2502146147 Toxic Policy at Dead End: the Case of Arsenic Prof. Gerhard Stohrer
- 2502146148-6153 Toxic Policy at Dead End: the Case of Arsenic
- 2502146154 the Asbestos Example Prof. J. Corbett Mcdonald
- 2502146155-6170 Linear Extrapolation for Risk Estimation at Low Level Exposure: the Asbestos Example
- 2502146171 the Case of Chlorine and Derivated Products Dr. Werner Freiesleben
- 2502146172-6185 the Case of Chlorine and Derivated Products (Vcm)
- 2502146186 the Ddt: Example Dr William Hazeltine
- 2502146201 Test of the Linear-No Threshold Theory of Radiation Carcinogenesis Prof. Bernard L. Cohen
- 2502146202-6219 Test Linear-No Threshold Theory of Radiation Carcinogenesis
- 2502146220 Bladder Cancer in Rats Fed Sodium Saccharin Dr. Clifford I. Chappel
- 2502146221-6238 Bladder Cancer in Rats Fed Sodium Saccharin - Mechanistic Data and Their Application in Risk Analysis
- 2502146239 Environmental Tobacco Smoke and Lung Cancer Approaches to Risk Assessment Prof. P.N. Lee
- 2502146240-6270 Environmental Tobacco Smoke and Lung Cancer Approaches to Risk Assessment
- 2502146271 Endeavouring New Shores in the Estimation and Assessment of the Cancer Risk by Environmental Materials (Abstract) Pr Erich Hecker (As Pr. Hecker's Paper Arrived Too Late to Be Included in the Program of the Morning Session, It Will Be Presented in the Afternoon).
- 2502146272-6275 Endeavouring New Shores in the Estimation and Assessment of the Cancer Risk by Environmental Materials
- 2502146276 Special Papers Health Effects of Historical Exposures to Asbestos Exposure-Response: Asbestos and Mesothelioma Prof. Douglas Lidell
- 2502146277-6283 Health Effects of Historical Exposures to Asbestos
- 2502146284-6285 Exposure-Response: Asbestos and Mesothelioma
- 2502146286-6293 Threshold Levels Some Thoughts
- 2502146295
- Area
- DEMPSEY,RUTH/OFFICE
- Named Organization
- Advisory Comm
- Anchor Serum
- Appropriations Subcomm
- Arch Env Health
- Arch Environm Cont + Tox
- Arch F Exp Path + Pharmak
- Arch Int Pharmacodyn
- Bionetics
- Bureau of Science
- Chemical Hygiene + Toxicology
- Clinical Toxicol
- Entomological Society of America
- Environmental Defense Fund
- Environmental Health Perspectives
- Epa, Environmental Protection Agency
- FDA, Food and Drug Administration
- Indust Med
- Industrial Med
- Int J Cancer
- Intl Center for Scientific Ecology
- J Natl Cancer Inst
- J Pharm + Exp Therap
- Jnci
- Lancet
- Mellon Inst
- Natl Pest Control Operators News
- NCI, Natl Cancer Inst
- NIH, Natl Inst of Health
- or State Univ
- Proc Soc Exp Biol + Med
- Q Bull Assoc
- Scientific Org
- Soc Toxicol
- Toxicology
- US Congress
- US Federal Register
- US Supreme Court
- Usda, U.S. Dept of Agriculture
- Vicente Books
- Anchor Serum
- Litigation
- Ppla/Produced
- Date Loaded
- 28 Jan 2000
- UCSF Legacy ID
- xaz22d00
Document Images
carry another dissolved chemical through cell walls, that otherwise might
not have been crossed by the chemical without the DMSO. .
Using a test where cancer was induced in mice by subdural implantation
of methyl-cholanthrene crystals, E.R.Laws (in a manuscript submitted to EPA
on May 13, 1970) reported that cells from this cancer could be transplanted
by injection of a saline suspension of cells into other mice. He also
reported that visual tumors developed in 10 to 18 days, with subsequent
relentless growth and eventual death of the mice as the normal consequence.
DDT administered at 5.5 mg/Kg/day gave preliminary evidence of prolonging
the life of the treated and challenged animals. There was some suggestion
that DDT had an adverse effect on the Sodium-Potassium-stimulated ATPase in
the tumor, and an alternative suggestion was that DDT might have a^general
subliminal toxic effect an the whole animal" which could make it a less
suitable host for the transplanted tumor.
A paper by R.P.H. Thompson et al.,1969. (Lancet II (7161):4-6, July 5,
1969) explains how DDT was administered to a 17 year old boy for control of
unconjugated juvenile jaundice. This treatment replaced phenobarbitone
which had been used earlier. The mechanism suggested for the successful
therapy was the induction of liver microsomal enzymes, which resulted in
reduced plasma bilirubin levels. The treatment resulted in producing an
elevated plasma DDT level, and for 7 months after the end of DDT therapy,
his biliruben level had remained low. The authors reported no side effects
were noticed, there was no proteinuria, and other liver function tests and
routine haematological tests remained normal.
A paper by Hazeltine in 1971 (Clinical Toxicol. 4:55-61), looked at
the Literature for evidence about DDT residues in people Living in
Agricultural areas, and the possible impact this chemical and other
agricultural chemicals might have on juvenile jaundice. The conclusions I
drew were that DDT appeared to be present in significant (+therapeutic)
levels in the body fat of people living in this area, that the observed
infants who were breast fed and had a reduced incidence of jaundice, could
be explained by the effects of this residue. There were other interesting
parts to this literature review, such as the competitive or counteracting
effect on liver enzyme induction by DDT, attributed to exposure to the
pesticide Malathion. " -
The competitive or antidotal effect of DDT and barbiturates was the
basis for hospital emergency room treatment of attempted barbiturtate
suicide cases with injected DDT. (Richard Rappolt Sr.,M.D., personal
communication) Dr. Rappolt treated at least two patients with DDT
dissolved in peanut oil; both patients were reported ambulatory and went
home the next day. This therapy evolved from the understanding of
veterinary practitioners who use barbiturates to antidote animals that have
organochlorine pesticide poisoning. Apparently the competitive antidotal
action explains the speed of effect, which is too fast for enzyme induction
and metabolism of the excess chemical. It was also interesting and sad to
see Dr. Rappolt dismissed from the hospital emergency room where he
practiced for reasons that appeared political. The published newspaper
story explained that he was dismissed for experimenting on people with
DDT; his reply was that a good emergency room physician must be ready for
all kinds of unusual situations.

Iz
Finally, while not directly dealing with cancer testing,'but still
bearing on the rat liver enzyme induction issue, two papers should be
mentioned. These are P.R.Datta 1970, and Datta and Nelson, 1970
(Industrial Med. 39:190-94 and 195-98). These papers report on a study in
which carbon 14 DDT and its metabolites were applied to perfused rat liver
and kidney slices, with the rate and metabolite production recorded. The
experiment was well quantified by accounting for the total radioactivity.
Each step of the metabolic process was confirmed by synthesizing the
molecules and applying each one to confirm the entire process. Keep in
mind that this was an in-vitro study and there was no fat sink to
preferentially adsorb (selectively partition) the highly lipid soluble
molecules, as would occur in a living rat. These workers showed that the
metabolism proceeded from DDT to DDA, a water soluble metabolic product.
The rats used in this test were preconditioned with DDT for three days
prior to the use of their tissues. These authors reported that the first
roughly two-thirds of the metabolism occurred in the liver, and the last
third in the kidney. The rates of metabolism were found to be quite rapid
in this isolated tissue system. The alleged persistent DDT metabolite in
nature (DDE) was degraded to DDA, with 14.5X of the DDE converted to DDA in
24 hours in untreated (unconditioned) animals, and 23.8% found as DDA after
12 hours in rats which had been conditioned for 3 days with DDT.
Susmary
In response to the format proposed for this Seminar, and looking for
significant correlations between forecasts and the facts available today,
it appears that the suggestions and predictions made in the 1970s about DDT
as a human carcinogen were only strawmen which have failed to occur. The
data from a number of studies showing some alleged adverse effects in mice
fed at maximum tolerated doses of DDT for lifetimes (more or less) is
suggestive but extremely difficult to interpret. At the same time, there
is evidence to refute the hypothesis that DDT is a human carcinogen. These
conflicts appear to occur for a number of reasons. Some of these reasons
are:
1. The choice of inappropriate test species and protocols to evaluate
DDT as a carcinogen, has led to a diversity of conflicting results. High
doses of DDT have seemed to produce random physiological effects, but these
conflicting data have had the tendency of making the whole process of
dose-response evaluations of the data for cancers remote, if not -
impossible. .
2. There is no clear data for the doses correlated with cancer
production in mice treated with large doses of DDT, in the literature I
have reviewed for this seminar. This suggests that DDT is not causally
related to the adverse conditions seen in the test mice, so other
explanations should be sought to explain the abnormal pathology which is
described.
3. People who work in "pure research" do not seem to be interested in
getting into the political arena, where their research findings may be
expected to be made to fit into some social framework, or to support some
I
cause.
4. Extrapolations of data that may provide some meaningful insights
may also involve some risk of being wrong. Therefore such extrapolations
2502146198

are usually avoided by "pure research" workers, and left to the
"apocalyptics", who do not seem to care much about accuracy or integrity.
5. Positive data on anticarcinogenic and therapeutic effects of DDT
are generally neglected, when looking at dose-response data. Most
researchers are looking for harmful effects. Society does not reward
findings of no harm.
6. There is a strong tendency to neglect the unprovable, such as the
evidence on improved vigor and increased life span for the human
population, which has been exposed to low levels of DDT for many years.
7. We need to examine the idea that a potential or weak organic
chemical carcinogen can also act in a way analogous to a therapeutic agent
at non-carcinogenic doses, to show beneficial actions within a
dose-response relationship. If there are both beneficial effects at low
dose, and harmful effects such as carcinogenicity at high dose, from the
same chemical molecule, then it could be appropriate to label a carcinogen
as beneficial. Selenium, the inorganic element may to provide a model for
this kind of thinking.
8. In any carcinogenic testing experiment, the most important question
concerns what is the highest dose which the test animal can tolerate
without loss of normal physiological body system functions. Doses
which cause loss of homeostasis are not expected to show reproducible
dose-response effects at any particular target site. This high dose loss
of homeostasis is the most reasonable way to interpret the alleged DDT
mouse cancer test data reviewed for this report.

GROUP
x 1
2
3
~~Z~z~~ - 4-
~~a+ -5 _
e;l y:<s:_~ x 6
~s~~~-
~
s~
3F ~Gi
Diet '
Stock .
Pu rified -
1
2
3
4
5.
6
x
Protein
Lu1nuu uvUiUtlcuG- Ulelu;AlhD CD-I7:1ICE E 5 /l . s~.
t(3-]2 mice necropsie:flsxlgraupl l~Gmc:i
PERCENTAGE \YttH TUMORS
- MULTIPLE LYMPHOMA- -
ANYTUMOR TUMORS LEU:EfdIIA LUNG. HEPATOMAS irASCULAI;
MALES '
.67 33 33 28 17 17
.57 7 -94 29 7 0
56' 13 ' 13 13 .
' 6_ 13
50 14 14 28
0 .:14
21 0 5 5 t5 0
r 72 16 22 44 ~6 6
.
FEMALES .
as 30 50 30 0.. 0
73 7 '7 60 0 0
' 69 23 15 23 ' 0 15
67 - 20 . 13 .33. 7- ' 13
17 35 - 24 ` 0
' 6
82
?3 5o
-23 .. .
0 , , :
18 :
Number of mice
x killed at and at 9:of survivors
Fat 80-tveek study with liver no3ules .1NC1 55; 37 1975.
26.3
2Z7
M
276 260
lot 121' -
8roup No. at
Mice Feeding+ Total
Tumours
by 18
months . Liver
Tumours Lung
Tumours Lympho- .-
Reticular
Neoplasms
OiheP
Neoptasms .
1- 40 4g. dietlday 4 1.. . 1 2 D
I mouselcage .
2 40 -1j. diet/day 4' 2-- 0 1 1 testis
I mouselwge -
'3- 40 Diet ad libitum 32 15' 2 11 2 testis
1 mouselcage ' - L kidney
I I thyroid
6 40 Oiet sd libitumX 23 8 " 6 9' , 0
5 micelcage
~ Autbred Swiss albino males maintained under SPF Conditions
+'5iandar.dpeileteddiet '
x 5.83. dictlday .
N
~
0
N
~
A
W
N
O
O
